#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    B-cell small lymphocytic lymphoma refractory Biliary neoplasm Non-Hodgkin's lymphoma unspecified histology aggressive recurrent Neurodegenerative disorder Growth hormone deficiency Erythema Alpha-1 antitrypsin deficiency Huntington's disease Hyperchylomicronaemia Leber's congenital amaurosis Bile acid synthesis disorder Congenital megacolon Systemic scleroderma Anal cancer recurrent Bone marrow disorder More trials…

    Learn about Rare Diseases

    VEXAS syndrome – Life with Disease Familial amyotrophic lateral sclerosis – Treatment Osteosarcoma recurrent – Life with Disease Gastrointestinal stromal tumour – Life with Disease Malignant fibrous histiocytoma – Diagnostics Cystic fibrosis Breast angiosarcoma metastatic – Life with Disease IgA nephropathy – Diagnostics Optic glioma – Treatment Rosai-Dorfman syndrome – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Mk-1088 Ima203Cd8 Maralixibat Chloride Ilofotase Alfa Trehalose Dihydrate (Ph.eur.) Clotrimazole Olopatadine Hydrochloride Isis 678354 Sodium Salt Methylprednisolone Aceponate Disodium Folinate Macitentan Ferric Carboxymaltose Sabestomig Eliglustat Tartrate Acetylcysteine LIGUFALIMAB Pamapimod Fianlimab Calcium Carbonate Remifentanil More therapies…

    Learn about Your Condition

    Plasma cell myeloma refractory Chronic sinusitis Cutaneous lupus erythematosus Breast cancer stage I Tardive dyskinesia Oesophageal atresia Athetosis Diffuse large B-cell lymphoma Neonatal asphyxia Drug use disorder Oesophageal achalasia Catatonia Ebola disease Triple negative breast cancer Hypophosphatasia More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Hemic and Lymphatic Diseases

  • Safety and efficacy of venetoclax, obinutuzumab and daratumumab in adult patients with relapsed chronic lymphocytic leukemia

    Not yet recruiting

    1 1 1 1
    Investigated Diseases:
    • Chronic lymphocytic leukaemia recurrent
    • Chronic lymphocytic leukaemia
    Investigated Drugs:
    • Obinutuzumab
    • Daratumumab
    • Venetoclax
    Poland

  • Evaluating venetoclax with drug combination in relapsed/refractory T‑cell acute lymphoblastic leukemia patients

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • T-cell type acute leukaemia
    Investigated Drugs:
    • Azacitidine
    • Everolimus
    • Tofacitinib
    Czechia France Germany The Netherlands Spain

  • Cemsidomide and Dexamethasone in Patients with Relapsed or Refractory Multiple Myeloma

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Plasma cell myeloma refractory
    France Italy Poland Spain

  • A study to evaluate the effectiveness of MC0518 (mesenchymal stromal cells) in adults with acute graft-versus-host disease that has not responded to steroids and ruxolitinib

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Acute graft versus host disease
    • Graft versus host disease
    Investigated Drugs:
    • Mesenchymal Stromal Cells, Ex Vivo Cultured
    Italy

  • A study to evaluate the effectiveness of REGN7508 for preventing blood clots in adults with solid tumors undergoing cancer treatment.

    Not yet recruiting

    3 1
    Investigated Diseases:
    • Embolism
    Investigated Drugs:
    • Regn7508
    Belgium Bulgaria Czechia France Germany Poland +2

  • A study to evaluate the use of colchicine to reduce inflammation in patients with deep vein thrombosis.

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Deep vein thrombosis
    • Pelvic venous thrombosis
    Investigated Drugs:
    • Colchicine
    Italy
Previous Page
1 … 36 37 38 39 40 … 89
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!